After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
NewAmsterdam Pharma Company NV is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of NewAmsterdam Pharma Company NV is $2.42B. A total of 0.54 million shares were traded on the day, compared to an average of 321.72K shares.
In the most recent transaction, Kooij Louise Frederika sold 45,000 shares of NAMS for 15.72 per share on Oct 01 ’24. After the transaction, the Chief Accounting Officer now owns 0 company shares. In a previous transaction on Oct 01 ’24, Kooij Louise Frederika bought 45,000 shares at 17.29 per share.
Among the insiders who bought shares, Audet Juliette Berangere acquired of 1,104 shares on Sep 26 ’24 at a per-share price of $15.70. This resulted in the Chief Business Officer holding 1,104 shares of NAMS after the transaction. In another insider transaction, Davidson Michael H. bought 5,000 shares at $16.27 per share on Aug 20 ’24. Company shares held by the Chief Executive Officer now total 209,784.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, NAMS has a high of $26.35 and a low of $8.64.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. NAMS’s latest balance sheet shows that the firm has $60.11M in Cash & Short Term Investments as of fiscal 2021. There were $185.68k in debt and $11.19M in liabilities at the time. Its Book Value Per Share was $4.11, while its Total Shareholder’s Equity was $56.37M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NAMS is Buy with a score of 4.78.
